Lupus (SLE) trials in China

In China 163 Also abroad 354

163 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.

No phaseEnrolling by invitationResearch participation
Study on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus
Where
Hefei
People
100
Run by
The First Affiliated Hospital of Anhui Medical University
See details and how to joinNCT07679776Registry updated 2026-07-01
Early phase 1RecruitingTrial-stage medicine
MTS109 in Patients With Refractory Autoimmune Diseases
Where
Shanghai
Age
18 years to 65 years
People
15
Run by
Shanghai Changzheng Hospital
See details and how to joinNCT07526350Registry updated 2026-06-30
Phase 1Not yet recruitingTrial-stage medicine
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
Where
Qingdao
Age
18 years to 70 years
People
18
Run by
The Affiliated Hospital of Qingdao University
See details and how to joinNCT07676266Registry updated 2026-06-30
Phase 1/2RecruitingTrial-stage medicine
A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus
Where
Beijing
Age
18 years to 65 years
People
218
Run by
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
See details and how to joinNCT06535412Registry updated 2026-06-29
Early phase 1RecruitingTrial-stage medicine
Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus
Where
Nanjing
Age
18 years to 65 years
People
15
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06946485Registry updated 2026-06-29
Early phase 1Not yet recruitingTrial-stage medicine
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases
Where
Hangzhou, Nanjing
Age
5 years to 20 years
People
30
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07674147Registry updated 2026-06-29
No phaseEnrolling by invitationTrial-stage medicine
CHT105 for the Treatment of Refractory Lupus Nephritis
Where
Nanjing
Age
18 years to 65 years
People
14
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07517536Registry updated 2026-06-18
Phase 2/3RecruitingTrial-stage medicine
Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia
Where
Beijing
Age
18 years to 65 years
People
164
Run by
Chinese SLE Treatment And Research Group
See details and how to joinNCT07657793Registry updated 2026-06-18
Phase 1RecruitingTrial-stage medicine
NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis
Where
Guangzhou
Age
18 years to 65 years
People
18
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT06676631Registry updated 2026-06-12
Early phase 1RecruitingTrial-stage medicine
Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA)
Where
Beijing
Age
18 years to 60 years
People
5
Run by
Circunited BioPharma (Shenzhen) Co., Ltd.
See details and how to joinNCT07629596Registry updated 2026-06-05
Early phase 1RecruitingTrial-stage medicine
Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients
Where
Shanghai
Age
18 years to 70 years
People
18
Run by
RenJi Hospital
See details and how to joinNCT05858684Registry updated 2026-06-01
Early phase 1RecruitingTrial-stage medicine
IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)
Where
Beijing
Age
18 years to 75 years
People
18
Run by
Peking University People's Hospital
See details and how to joinNCT07617740Registry updated 2026-06-01
No phaseNot yet recruitingTrial-stage medicine
A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases
Where
Beijing
Age
18 years to 75 years
People
75
Run by
Beijing GoBroad Hospital
See details and how to joinNCT07593911Registry updated 2026-05-18
Phase 3RecruitingTrial-stage medicine
A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus
Where
Beijing
Age
18 years to 80 years
People
316
Run by
Beijing Mabworks Biotech Co., Ltd.
See details and how to joinNCT07405970Registry updated 2026-05-05
No phaseRecruitingTrial-stage medicine
Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
Where
Nanjing
Age
18 years to 70 years
People
72
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07558850Registry updated 2026-04-30
No phaseRecruitingResearch participation
Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
Where
Shanghai
Age
7 years to 17 years
People
60
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07425730Registry updated 2026-04-28
Phase 2RecruitingTrial-stage medicine
A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)
Where
Linfen
Age
18 years to 70 years
People
120
Run by
InventisBio Co., Ltd
See details and how to joinNCT07311200Registry updated 2026-04-24
Early phase 1Not yet recruitingTrial-stage medicine
Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy
Where
Xi'an
Age
18 years to 65 years
People
15
Run by
Air Force Military Medical University, China
See details and how to joinNCT07535138Registry updated 2026-04-16
Early phase 1RecruitingTrial-stage medicine
A Study of CC312 for Relapsed/Refractory Autoimmune Diseases
Where
Deyang
Age
18 years to 65 years
People
6
Run by
CytoCares Inc
See details and how to joinNCT07193810Registry updated 2026-04-14
Phase 1/2RecruitingTrial-stage medicine
SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
Where
Shenzhen
Age
18 years to 70 years
People
24
Run by
Beijing Biotech
See details and how to joinNCT07523542Registry updated 2026-04-13
Phase 1Not yet recruitingTrial-stage medicine
Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus
Where
Wuhan
Age
18 years to 75 years
People
30
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07512947Registry updated 2026-04-06
Early phase 1RecruitingTrial-stage medicine
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases
Where
Hangzhou
Age
5 years and over
People
36
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07490041Registry updated 2026-03-24
No phaseRecruitingTrial-stage medicine
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
Where
Wuhan
Age
18 years to 70 years
People
12
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07470151Registry updated 2026-03-13
Phase 2RecruitingTrial-stage medicine
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
Where
Nanjing
Age
14 years to 65 years
People
50
Run by
Nanjing University School of Medicine
See details and how to joinNCT07340463Registry updated 2026-03-12
Phase 1/2RecruitingTrial-stage medicine
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
Where
Beijing
Age
3 years to 65 years
People
18
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06585514Registry updated 2026-03-10

All Lupus (SLE) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error